Metabolomics in cell culture-A strategy to study crucial metabolic pathways in cancer development and the response to treatment

被引：67

作者：

Halama, Anna ^{[1
]}

机构：

[1] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar

来源：

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 2014年 / 564卷

关键词：

Metabolomics; Metabolic alterations; Cell culture; Cancer cell lines; Drug screening; BREAST-CANCER; PANCREATIC-CANCER; MASS-SPECTROMETRY; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; PROFILING REVEALS; NMR METABOLOMICS; GENE-EXPRESSION; ACID PROFILES; OVARIAN;

D O I：

10.1016/j.abb.2014.09.002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Metabolomics is a comprehensive tool for monitoring processes within biological systems. Thus, metabolomics may be widely applied to the determination of diagnostic biomarkers for certain diseases or treatment outcomes. There is significant potential for metabolomics to be implemented in cancer research because cancer may modify metabolic pathways in the whole organism. However, not all biological questions can be answered solely by the examination of small molecule composition in biofluids; in particular, the study of cellular processes or preclinical drug testing requires ex vivo models. The major objective of this review was to summarise the current achievement in the field of metabolomics in cancer cell culture focusing on the metabolic pathways regulated in different cancer cell lines and progress that has been made in the area of drug screening and development by the implementation of metabolomics in cell lines. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：100 / 109

页数：10

共 156 条

[41]

Earle W.R., 1943, JNCI-J NATL CANCER I, V4, P122

[42] The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism [J].

Engelman, Jeffrey A. ;

Luo, Ji ;

Cantley, Lewis C. .

NATURE REVIEWS GENETICS, 2006, 7 (08) :606-619

[43] Pathway-specific differences between tumor cell lines and normal and tumor tissue cells [J].

Ertel, Adam ;

Verghese, Arun ;

Byers, Stephen W. ;

Ochs, Michael ;

Tozeren, Aydin .

MOLECULAR CANCER, 2006, 5 (1)

[44]

FDA, 2004, INN STAGN CHALL OPP

[45]

Fernandez-Albert F., 2014, BIOINFORMATICS

[46] Metabolite profiling for plant functional genomics [J].

Fiehn, O ;

Kopka, J ;

Dörmann, P ;

Altmann, T ;

Trethewey, RN ;

Willmitzer, L .

NATURE BIOTECHNOLOGY, 2000, 18 (11) :1157-1161

[47] Mass Spectrometry-Based Metabolic Profiling of Gemcitabine-Sensitive and Gemcitabine-Resistant Pancreatic Cancer Cells [J].

Fujimura, Yoshinori ;

Ikenaga, Naoki ;

Ohuchida, Kenoki ;

Setoyama, Daiki ;

Irie, Miho ;

Miura, Daisuke ;

Wariishi, Hiroyuki ;

Murata, Masaharu ;

Mizumoto, Kazuhiro ;

Hashizume, Makoto ;

Tanaka, Masao .

PANCREAS, 2014, 43 (02) :311-318

[48] Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers [J].

Fujitani, Naoki ;

Furukawa, Jun-ichi ;

Araki, Kayo ;

Fujioka, Tsuyoshi ;

Takegawa, Yasuhiro ;

Piao, Jinhua ;

Nishioka, Taiki ;

Tamura, Tomohiro ;

Nikaido, Toshio ;

Ito, Makoto ;

Nakamura, Yukio ;

Shinohara, Yasuro .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (06) :2105-2110

[49] Diagnosis of Early Stage Ovarian Cancer by 1H NMR Metabonomics of Serum Explored by Use of a Microflow NMR Probe [J].

Garcia, Erwin ;

Andrews, Chris ;

Hua, Jia ;

Kim, Hyung L. ;

Sukumaran, Dinesh K. ;

Szyperski, Thomas ;

Odunsi, Kunle .

JOURNAL OF PROTEOME RESEARCH, 2011, 10 (04) :1765-1771

[50]

Gey C., 1952, CANC RES

← 1 2 3 4 5 6 7 8 9 10 →